Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc.
| Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. |
| Ascent Pharmaceuticals, Inc. |
| 1:2023cv00486 |
| May 3, 2023 |
| US District Court for the District of Delaware |
| Joseph F Bataillon |
| Christopher J Burke |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 23, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED D.I. #11 STIPULATION TO EXTEND TIME respond to complaint to July 26, 2023 filed by Ascent Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Ascent Pharmaceuticals, Inc. answer due 7/26/2023. Ordered by Judge Christopher J. Burke on 6/23/2023. (mlc)
|
| Filing 11 STIPULATION TO EXTEND TIME respond to complaint to July 26, 2023 - filed by Ascent Pharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd. Astellas Pharma Global Development, Inc., Astellas Pharma Inc.,J Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) |
| Pro Hac Vice Attorney Nitya Anand for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) |
|
SO ORDERED D.I. #9 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 5/23/2023. (dlb)
|
| Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: #https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) |
|
SO ORDERED D.I. #8 Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., Reset Answer Deadline: Ascent Pharmaceuticals, Inc. answer due 6/26/2023. Ordered by Judge Christopher J. Burke on 5/23/2023. (dlb)
|
| Pro Hac Vice Attorney Simon D. Roberts and Rodney D. Swartz, II for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mpb) |
| Pro Hac Vice Attorney Connor S. Romm for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mkr) |
| REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:#http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) |
|
Filing 10
ORAL ORDER: Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 05/22/2023. (AEV)
|
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz)(Joyce, Alexandra) |
| Filing 8 STIPULATION regarding Venue and Personal Jurisdiction and to Extend Time for Response to Complaint by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Filing 7 DECLARATION of Service on Ascent Pharmaceuticals, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) |
| Filing 6 Summons Issued as to Ascent Pharmaceuticals, Inc. on 5/3/2023. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd., Astellas Pharma Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/22/2023. Date of Expiration of Patent: 09/28/2029.Thirty Month Stay Deadline: 9/22/2025. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ascent Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4127096.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
